|
2024
|
Invention
|
Prophylactic and/or ameliorating agent for peripheral neuropathy caused by cancer chemotherapeuti... |
|
|
Invention
|
Anti-aplp1 monoclonal antibody and use thereof. The present invention pertains to: an anti-APLP1 ... |
|
|
Invention
|
Method for reducing or removing si, fe, and cu in aluminum alloy. [Problem] The purpose of the pr... |
|
|
Invention
|
Method and device for supplying to catalyst. 33233. |
|
|
Invention
|
Pharmaceutical for treating or preventing chemotherapy-induced peripheral neuropathy. Provided is... |
|
2023
|
Invention
|
Nucleocapsid-derived antigen peptide, nucleic acid, vector, pharmaceutical composition, hla/antig... |
|
|
Invention
|
Prophylactic or therapeutic agent for periostin-mediated disease and pruritus associated therewit... |
|
|
Invention
|
Supplying method and supplying device targeting catalyst. 33233. |
|
|
Invention
|
Catalyst, method for manufacturing same, and method for manufacturing liquid fuel. The purpose of... |
|
|
Invention
|
Random copolymer, fine particle adsorbent, composition for forming fine particle-adsorbing coatin... |
|
|
Invention
|
Pharmaceutical or food and beverage composition for prevention or treatment of optic nerve disord... |
|
|
Invention
|
Novel inflammatory disease treatment agent and screening method for same. The present invention p... |
|
|
Invention
|
Liquid hydrocarbon production method and liquid hydrocarbon production device. 24222 through a st... |
|
|
Invention
|
Hydrocarbon synthesis catalyst, method for manufacturing same, and method for synthesizing hydroc... |
|
|
Invention
|
Cell for treating burn and burn treatment method. The present invention addresses the problem of ... |
|
|
Invention
|
Novel pharmaceutical composition. The present invention addresses the problem of providing a nove... |
|
|
Invention
|
Novel pharmaceutical composition. A purpose of the present invention is to provide a novel pharma... |
|
|
Invention
|
Glutaminase inhibitor. The purpose of the present invention is to provide a glutaminase inhibitor... |
|
2022
|
Invention
|
Compound having anticancer effect. The present invention pertains to a compound represented by fo... |
|
|
Invention
|
T-type calcium channel blocker.
The present invention provides a compound of formula (I):
The ... |
|
|
Invention
|
T-type calcium channel blocker. The present invention provides a compound that has a T-type calci... |
|
|
Invention
|
T-type calcium channel blocker. The present invention provides a compound of formula (I) wherein ... |
|
|
Invention
|
Anti-cd206 antibody and use thereof. The present invention addresses the problem of providing: an... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating cancer. The present invention addresses the... |
|
|
Invention
|
Agent for prevention, treatment, and/or improvement of neurodegenerative disease. Provided is an ... |
|
|
Invention
|
Method for detecting virus-neutralizing antibodies. Provided is a method for evaluating virus-neu... |
|
|
Invention
|
Organic electroluminescent element. This organic electroluminescent element 10 comprises a plural... |
|
|
Invention
|
Anti-sars-cov-2 antibody. The present invention addresses the problem of providing a novel and ef... |
|
2021
|
Invention
|
Antibody capable of binding specifically to 5′ to 3′ exonuclease active domain of dna polymerase.... |
|
|
Invention
|
Antibody capable of binding specifically to 5'→3' exonuclease active domain of dna polymerase. Pr... |
|
|
Invention
|
Biodegradable medical implement. To ensure that a biodegradable medical implement dissolves in vi... |
|
|
Invention
|
Biodegradable medical implement. The purpose of the present invention is to have biodegradable me... |
|
|
Invention
|
Cystic lymphangioma treatment drug.
A pharmaceutical composition for preventing or treating cyst... |
|
|
Invention
|
Cystic lymphangioma treatment drug. Provided is a pharmaceutical composition for preventing or tr... |
|
|
Invention
|
Antibody capable of binding specifically to nucleocapsid protein of severe acute respiratory synd... |
|
|
Invention
|
Development of pancreatic cancer biomarker using feces-derived protein. A pancreatic cancer test ... |
|
|
Invention
|
Analgesic drug using nr4a1 antagonist. The present invention pertains to: a compound represented ... |
|
|
Invention
|
Betaine monomer, polymer, composition containing said polymer, and molded object. The present inv... |
|
|
Invention
|
Antidepressant/anxiolytic drug in which pac1 receptor antagonist is used. The present invention r... |
|
2020
|
Invention
|
Tool for inspecting/treating benign paroxysmal positional vertigo. Provided is a tool for inspect... |
|
|
Invention
|
Burn restoration material.
A raw amniotic membrane placed in a processing tank (10) is continuou... |
|
|
Invention
|
Burn repairing material. A raw amniotic membrane placed in a processing tank (10) is continuously... |
|
|
Invention
|
Filling/cushioning member for skin grafts on auricular skin defects.
The present invention addre... |
|
|
Invention
|
Skin graft supplementing/cushioning member for auricle skin defect. The present invention address... |
|
|
Invention
|
Wound contact member. The present invention addresses the problem of providing a wound contact me... |
|
|
Invention
|
Model animal for bipolar disorder. The present invention provides a nonhuman model animal for bip... |
|
|
Invention
|
Ultrasonic tomogram generation method, ultrasonic tomogram generation apparatus, and program.
Pr... |
|
2018
|
Invention
|
Substrates coated with selective cell separation or cell culture polymers. 3, m1, m2 and n are as... |
|
|
Invention
|
Method for determining bacterial number in specimen.
A method for enabling rapid and accurate de... |
